EU countries can soon start vaccinating children as young as five against COVID-19 after the European Medicines Agency said the BioNTech/Pfizer COVID-19 vaccine was safe and effective in younger kids.
The EMA’s medicines committee CHMP recommended Thursday that the vaccine is given as two doses three weeks apart to those aged five to 11. The dose in this age group is one third of the amount given to those aged 12 and older, the EMA said.
A study in this age range showed this lower dose elicited a similar antibody response to those seen in adults aged 16 to 25.
A placebo-controlled study of nearly 2,000 children aged five
→ Continue reading at Politico